Ebola Outbreak in the Democratic Republic of the Congo
The World Health Organization has escalated its assessment of the Ebola outbreak in the Democratic Republic of the Congo, now deeming the risk as “very high.” This shift comes as officials report a troubling surge, with nearly 750 suspected cases and 177 related deaths, a significant increase from the earlier figures of 246 cases and 65 deaths reported just a week ago.
Dr. Tedros Adhanom Ghebreyesus, the WHO director-general, expressed that the current situation is “deeply worrisome.”
A more alarming incident occurred on Thursday when a treatment center in Rwampara, located in Ituri province, faced hostility. Medical staff attempted to set up facilities outside a hospital, but a fire broke out after locals, upset about being unable to retrieve the body of a deceased resident, attacked the area. To curb the spread of the virus, Ebola fatalities must be buried following strict protocols.
Dr. Tedros highlighted that there is a notable “distrust of outside authorities” among the local population, complicating the outbreak response. He emphasized the need to build trust within affected communities, stating that it is crucial for a successful intervention.
Dr. Anne Ancia, the WHO’s representative in the DRC, mentioned that the assault on the treatment center could significantly hinder efforts to tackle the outbreak. This center was intended to isolate Ebola patients from others receiving care in the hospital. However, she remained optimistic that operations could resume within 24 hours.
This outbreak is due to the Bundibugyo strain of Ebola, which unfortunately lacks any available vaccines or specific treatments. Most of the reported cases are concentrated in Ituri province, with a few scattered instances in other regions and two cases in Uganda.
Interestingly, health officials suggested that the rise in cases might reflect improved detection efforts—a “good sign” despite the alarming numbers. There has been a slight decrease in the proportion of samples testing positive, indicating that more individuals with symptoms are being identified.
Yet, Dr. Ancia warned, “We are running behind; we are not yet under control.”
Despite this, she expressed confidence in the response team’s ability to manage the outbreak effectively, stating, “I can guarantee you that together, we will manage to get over this outbreak as soon as we can.”
While the WHO’s risk assessment for the DRC has increased, its evaluation of risk at the regional and global levels remains high and low, respectively.
Representatives from humanitarian organizations in Ituri expressed concerns over insufficient resources to mount an effective response. Dr. Amadou Bocoum, the country director for Care International in the DRC, noted that recent aid cuts have led to equipment shortages, compromising the system’s functionality. Additionally, fewer staff have made the labor-intensive tasks of case identification and contact tracing more challenging.
Julie Drouet, country director for Action Against Hunger, remarked on the urgency of the situation, stating, “Everyone is working to try to implement as quickly as possible. However, it is not quite yet ready. It is not really yet up to the emergency that we have in Congo at the moment.”
In a recent WHO press briefing, it was discussed that researchers have identified an antiviral drug, obeldesivir, that could potentially help prevent individuals in contact with Bundibugyo cases from developing the disease, and plans are in motion to initiate trials in affected areas.
